[Form 4] TSS, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Daniel M. Chism, listed as Chief Financial Officer of TSS, Inc. (TSSI), reported sales of company common stock on 08/27/2025 and 08/28/2025. The Form 4 shows a sale of 10,000 shares on 08/27/2025 at a weighted average price of $16.25 and a sale of 5,000 shares on 08/28/2025 at $16.20. The report records beneficial ownership of 316,219 shares following the 08/27 sale and 311,219 shares following the 08/28 sale. The filing is signed by an attorney-in-fact, Christopher R. Johnson, dated 08/29/2025. The filer affirms willingness to provide transaction-level price details within the disclosed price range.

Positive

• Timely disclosure: Form 4 was filed with signature dated 08/29/2025, providing required insider sale reporting.
• Detailed pricing footnote: The filer offers to supply per-trade prices within the disclosed weighted-average range, enhancing transparency.

Negative

• Officer dispositions: The Chief Financial Officer sold a total of 15,000 shares across two days, reducing reported beneficial ownership from 316,219 to 311,219 after the second sale.
• No indication of plan-based sales: The form does not indicate these sales were made pursuant to a Rule 10b5-1 plan, which some investors use to reduce concerns about timing.

Insights

Securities Analyst

TL;DR: Company CFO sold 15,000 TSSI shares across two days; filings disclose post-sale ownership and weighted average sale prices.

The Form 4 documents two non-derivative dispositions by CFO Daniel M. Chism totaling 15,000 common shares executed on 08/27/2025 and 08/28/2025. Reported prices are a weighted average of $16.25 for the first date and $16.20 for the second; the filer notes transaction prices ranged from $16.245 to $16.26 for the 08/27 sales. Beneficial ownership is recorded as 316,219 shares after the 08/27 sale and 311,219 after the 08/28 sale. The filing is executed by an attorney-in-fact on 08/29/2025, indicating formal disclosure compliance. No other transactions, derivates, or plan-based sales are disclosed in this Form 4.

Corporate Governance Expert

TL;DR: Insider sales were disclosed promptly and show a modest reduction in CFO's holdings; no derivative activity or plan-based sale indicated.

The filing indicates straightforward open-market dispositions rather than exercises or derivative transactions. The report includes a disclosure footnote offering to provide per-trade price details, which increases transparency. There is no evidence in this filing of Rule 10b5-1 plan sales or of any unusual related-party transactions. Based solely on the Form 4 content, the transaction appears to be a routine sale by an officer with post-transaction holdings clearly stated.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHISM DANIEL M

(Last) (First) (Middle)

C/O TSS, INC. 1800 AVIATION DRIVE

BUILDING 1, SUITE 100

(Street)

GEORGETOWN TX 78628

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TSS, Inc. [ TSSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		S		10,000	D	$16.25(1)	316,219	D
Common Stock	08/28/2025		S		5,000	D	$16.2	311,219	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.245 to $16.26, inclusive. The reporting person undertakes to provide to TSS, Inc., any security holder of TSS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Christopher R. Johnson, Attorney-in-Fact	08/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did TSSI insider Daniel M. Chism report on Form 4?

The Form 4 reports sales of 10,000 shares on 08/27/2025 at a weighted average price of $16.25 and 5,000 shares on 08/28/2025 at $16.20.

How many TSSI shares does the reporting person own after the reported transactions?

The filing shows beneficial ownership of 316,219 shares following the 08/27/2025 sale and 311,219 shares following the 08/28/2025 sale.

Was the Form 4 filed and signed, and by whom?

Yes. The Form 4 bears the signature of Christopher R. Johnson, Attorney-in-Fact, dated 08/29/2025.

Are the reported sale prices exact per-trade figures?

The 08/27/2025 price is reported as a weighted average; the footnote states trades ranged from $16.245 to $16.26 and the filer will provide per-trade details upon request.

Do these entries indicate sales under a 10b5-1 trading plan?

No. The form does not indicate that these transactions were made pursuant to a Rule 10b5-1 trading plan.